← Leaderboards
Neil T Parkin
Monogram Biosciences, Inc.
$2,329,583
Attributed
$2,329,583
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $832.7K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$2,329,583 · 3
By mechanism
R43$1,198,023 · 2
R44$1,131,560 · 1
Top collaborators
No co-investigators on record.
Most similar at Monogram Biosciences, Inc.
Same institution · by research overlap
- Christos J Petropoulos$13,434,107
- Colombe Chappey$2,330,496
Others in their field
Top investigators on “Technology /Technique Development”
- Eric S Lander · Whitehead Institute For Biomedical Res$242,268,294
- Richard K. Wilson · Washington University$145,541,485
- Robert H Waterston · Washington University$144,225,057
- Ronald Wayne Davis · Stanford University$43,786,494
- Andrzej Joachimiak Joachimiak · University Of Chicago$33,231,516
- Deirdre R. Meldrum · University Of Washington$26,048,264
Research focus
Technology /Technique DevelopmentDrug ResistanceAntiviral AgentsHepatitis C VirusCytologyCell MorphologyDrug Screening /EvaluationRepliconCell Population StudyHuman TissueRecombinant VirusClinical TrialsClinical ManagementClinical Trials, Phase IiEnsureClassCaliforniaCharacteristicsDesignCertificationBaseEndopeptidasesDecision MakingCells
Grant awards (6)
Novel Assays for measuring Integrase and RNase-H Inhibition$599,357
R44 · FY2007 · AI · contact PI
Novel Assays for measuring Integrase and RNase-H Inhibition$532,203
R44 · FY2006 · AI · contact PI
Drug susceptibility assay for non-subtypr B HIV-1$300,502
R43 · FY2006 · AI · contact PI
Drug susceptibility assay for non-subtypr B HIV-1$298,417
R43 · FY2005 · AI
A cell-based assay to measure HCV drug susceptibility$299,768
R43 · FY2004 · AI
A cell-based assay to measure HCV drug susceptibility$299,336
R43 · FY2003 · AI